Freedom of Information request (FOI 22/945)
Published 17 January 2024
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/freedom-of-information-responses-from-the-mhra-week-commencing-12-september-2022/freedom-of-information-request-foi-22945
FOI 22/945
14th September 2022
Dear
Thank you for your FOI request dated 7th September 2022.
We can confirm that we do not hold the information that you have requested. As the original marketing authorisation application for “Cardicor (Bisoprolol fumarate) 1.25, 2.5, 3.75, 5, 7.5, 10 mg Film-coated Tablets of Merck Serono Limited” was made prior to the 2012 amendment in pharmacovigilance legislation, which requires an RMP for all new applications, the MHRA does not hold an RMP for this product.
If you have a query about the information provided, please reply to this email.
Please remember to quote the reference number above in any future communications.
Yours sincerely
FOI Team,
Safety and Surveillance